Cargando…
Genetic mutations associated with sensitivity to neoadjuvant chemotherapy in metastatic colon cancer: A case report and review of literature
BACKGROUND: Colorectal liver metastases (CLM) occur in 15%-30% of patients with colorectal cancer (CRC). Advancements in next generation sequencing (NGS) can provide more precise prognoses for cancer patients and help guide clinical treatment. However, the genetic variants that predict high sensitiv...
Autores principales: | Zhao, Long, Wang, Quan, Zhao, Shi-Dong, Zhou, Jing, Jiang, Ke-Wei, Ye, Ying-Jiang, Wang, Shan, Shen, Zhan-Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409210/ https://www.ncbi.nlm.nih.gov/pubmed/34540965 http://dx.doi.org/10.12998/wjcc.v9.i24.7099 |
Ejemplares similares
-
In Reply: Overall Survival of Resectable Metastatic Colon Cancer Treated With Neoadjuvant Chemotherapy or Adjuvant Chemotherapy in Non-academic Program
por: Hao, Zhonglin, et al.
Publicado: (2023) -
Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs
por: Hao, Zhonglin, et al.
Publicado: (2022) -
Meta-analysis of neoadjuvant immunotherapy for non-metastatic colorectal cancer
por: Zhou, Long, et al.
Publicado: (2023) -
Neoadjuvant Chemotherapy for Colon Cancer
por: Roth, Marc T., et al.
Publicado: (2020) -
HER2 changes to positive after neoadjuvant chemotherapy in breast cancer: A case report and literature review
por: Wang, Luo, et al.
Publicado: (2022)